— Approval based on results from global Phase III FRESCO-2 trial in patients with previously treated metastatic colorectal cancer — —…
The approval of QUVIVIQ™, a novel dual orexin receptor antagonist, is based on robust clinical efficacy and safety data, including…
Proceeds will be used to advance the Company’s IMANs into clinical trialsRaise underpins strong pre-clinical data demonstrating dual mechanism of…
Allschwil, Switzerland, September 24, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs…
Toronto, Ontario--(Newsfile Corp. - September 24, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a…
London, United Kingdom--(Newsfile Corp. - September 24, 2024) - Edison issues report on Metals One (LSE: MET1).Metals One is a…
New Zeki Data Report Breaks Down Competition Within the Deep-Tech Ecosystem LONDON, Sept. 24, 2024 /PRNewswire/ -- A new global…
SHANGHAI, Sept. 24, 2024 /PRNewswire/ -- At the TECH4ALL Digital Inclusion Forum hosted at Huawei Connect 2024, Huawei called for more…
NEW YORK, Sept. 24, 2024 /PRNewswire/ -- Compliancy Group releases the Texas HB 300 program, including policy templates and program…
Featuring a revolutionary new sleep product, SleepMask, along with SmartGoggles 2nd Generation, Theragun Prime Plus, JetBoots PRO Plus, and JetBoots…